Fluticasone propionate placebo

DRUG3 trials

Sponsors

Boehringer Ingelheim, GlaxoSmithKline, Organon and Co

Conditions

AsthmaRhinitis, Allergic, Seasonal

Phase 2

BI 671800 ED in Steroid-naive Asthmatic Patients

CompletedNCT01092143

Boehringer IngelheimAsthma

Start: 2010-03-18End: 2011-03-26Updated: 2022-05-31

Phase 3

A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects

CompletedNCT02094937

GlaxoSmithKlineAsthma

Start: 2014-03-27End: 2015-08-28Updated: 2017-05-25

Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)

CompletedNCT03882047

Organon and CoRhinitis, Allergic, Seasonal

Start: 1994-08-11End: 1994-09-16Updated: 2022-02-09